AMEND news in 2021
-
NANETS COVID-19 Vaccination Position Statement
Given that neuroendocrine tumors are common among MEN patients, we’d like to highlight a recent COVID-19 vaccination position statement released by the North American Neuroendocrine Tumor Society (NANETS).
Click to learn more
-
2021 WorldMEN Conference
The WorldMEN conference is attended by a wide audience of endocrinologists, surgeons, gastroenterologists, oncologists, geneticists and more, all concerned by the diagnosis and management not only of multiple endocrine neoplasia, endocrine tumor syndromes and the various diseases they include (Von Hippel Lindau disease, pheochromocytoma and paraganglioma, pituitary tumors, neuroendocrine tumors, neurofibromatosis, calcium disorders…), but also endocrine cancers in general.
Click to learn more
-
New Website and Mailing List
Toward the end of 2020, AMEND USA achieved its goal of having a website and contact list separate from the AMEND organization based out of the UK.
Click to learn more